Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Vinpocetine
Therapeutic Area : Neurology
Study Phase : Approved
Sponsor : Nika Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Acquisition
Nika Pharmaceuticals Acquires Technologies for Three Drugs and One Supplement
Details : The acquisition includes technologies for producing generics as tablet, Vinpocetine, Menthyl Valerate, and Metamizole Sodium, and a dietary supplement, Tribulus Terrestris Herba Extractum Siccum.
Brand Name : Vinpocetine-Generic
Molecule Type : Small molecule
Upfront Cash : Undisclosed
April 15, 2024
Lead Product(s) : Vinpocetine
Therapeutic Area : Neurology
Highest Development Status : Approved
Sponsor : Nika Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Acquisition
LOOKING FOR A SUPPLIER?